Search PubMed⌕ Search

Biomedical subjects

P Beck

Publications and source records attributed to P Beck.

At least 19 recordsLinked to original sources

The results of cosmic radiation in-flight TEPC measurements during the CAATER flight campaign and comparison with simulation.

The European-Commission-supported project DOSMAX (Dosimetry of Aircrew Exposure to Radiation During Solar Maximum) was aimed at measuring aircrew exposure to cosmic radiation on-board the aircraft during solar maximum. During a dedicated international comparison mission (Co-ordinated Access to Aircraft for Transnational Environmental Research; CAATER) different measurement techniques have been compared by six European institutes (Results of the CAATER Mission, DOSMAX Meeting, Dublin, June 2004). In this paper, we present the tissue-equivalent proportional counter (TEPC) measurements carried out by ARC Seibersdorf research (ARCS), Austria, and Institut de Radioprotection et de Sûreté Nucléaire (IRSN), France, together with a comparison with simulation results under the same conditions. The whole flight campaign consists of four different in-flight investigations performed at two different geographical positions at 12.2 km (FL 400) and 9.8 km (FL 320). One location was chosen above Rome (42 degrees North, 12 degrees East), Italy, for high cut-off rigidity (6.4 GV) and the second above Aalborg (57 degrees North, 10 degrees East), Denmark, for low cut-off rigidity (1.8 GV). The TEPC measurements are presented in terms of absorbed dose and ambient dose equivalent as well as microdosimetric spectra as a function of lineal energy. For the same conditions of the CAATER flights the response of the TEPC has also been simulated by using the Monte Carlo Transport Code FLUKA (version 2003). The results from simulations are compared with measurements and they show a reasonable agreement.

Aviation↗

Production of 3-hydroxypropionaldehyde using a two-step process with Lactobacillus reuteri.

3-Hydroxypropionaldehyde (3-HPA) produced by Lactobacillus reuteri is a broad-spectrum antimicrobial substance of glycerol conversion. The aim of the present work was to optimize 3-HPA production by Lb. reuteri ATCC 53608 using a two-step process. The first step was the production of Lb. reuteri cells in optimal conditions. Cells were then harvested by centrifugation and suspended in glycerol solution, which the resting cells bioconverted to 3-HPA. The effect of biomass concentration, temperature, glycerol concentration, anaerobic/micro-aerophilic conditions, and incubation time was studied for high 3-HPA production. 3-HPA accumulation was limited by the death of cells in contact with high concentrations of 3-HPA. However, a very high 3-HPA concentration of 235+/-3 mM was obtained after 45 min of incubation at 30 degrees C in 400 mM glycerol for an initial free-cell concentration of 1.6+/-0.3x10(10) viable cells/ml. A high viability was maintained at low temperatures in the range 5-15 degrees C, but with a slightly lower yield of 3-HPA at 5 degrees C compared with higher temperatures, up to 37 degrees C. Successive 1-h incubations of Lb. reuteri cells in 200 mM glycerol at 15 degrees C to tentatively reuse the cells resulted in decreasing 3-HPA concentrations at the end of each cycle, with two successful production cycles yielding high 3-HPA concentrations of 147+/-1 mM and 128+/-2 mM.

Aldehydes↗

Timescales of shock processes in chondritic and martian meteorites.

The accretion of the terrestrial planets from asteroid collisions and the delivery to the Earth of martian and lunar meteorites has been modelled extensively. Meteorites that have experienced shock waves from such collisions can potentially be used to reveal the accretion process at different stages of evolution within the Solar System. Here we have determined the peak pressure experienced and the duration of impact in a chondrite and a martian meteorite, and have combined the data with impact scaling laws to infer the sizes of the impactors and the associated craters on the meteorite parent bodies. The duration of shock events is inferred from trace element distributions between coexisting high-pressure minerals in the shear melt veins of the meteorites. The shock duration and the associated sizes of the impactor are found to be much greater in the chondrite (approximately 1 s and 5 km, respectively) than in the martian meteorite (approximately 10 ms and 100 m). The latter result compares well with numerical modelling studies of cratering on Mars, and we suggest that martian meteorites with similar, recent ejection ages (10(5) to 10(7) years ago) may have originated from the same few square kilometres on Mars.

Journal Article↗

FLUKA simulation of TEPC response to cosmic radiation.

The aircrew exposure to cosmic radiation can be assessed by calculation with codes validated by measurements. However, the relationship between doses in the free atmosphere, as calculated by the codes and from results of measurements performed within the aircraft, is still unclear. The response of a tissue-equivalent proportional counter (TEPC) has already been simulated successfully by the Monte Carlo transport code FLUKA. Absorbed dose rate and ambient dose equivalent rate distributions as functions of lineal energy have been simulated for several reference sources and mixed radiation fields. The agreement between simulation and measurements has been well demonstrated. In order to evaluate the influence of aircraft structures on aircrew exposure assessment, the response of TEPC in the free atmosphere and on-board is now simulated. The calculated results are discussed and compared with other calculations and measurements.

Aerospace Medicine↗

Meta-analysis of short-acting insulin analogues in adult patients with type 1 diabetes: continuous subcutaneous insulin infusion versus injection therapy.

AIMS/HYPOTHESIS: This study aimed to compare the effect of treatment with short-acting insulin (SAI) analogues versus structurally unchanged short-acting insulin (regular insulin) on glycaemic control and on the risk of hypoglycaemic episodes in type 1 diabetic patients using different insulin treatment strategies. METHODS: We performed a meta-analysis of 27 randomised controlled trials that compared the effect of SAI analogues with regular insulin in patients with type 1 diabetes mellitus. The treatments were administered either via continuous subcutaneous insulin infusion (CSII) or by conventional intensified insulin therapy (IIT) with short-acting insulin injections before meals and basal insulin administered once or twice daily in most cases. RESULTS: HbA(1)c levels were reported for 20 studies. For studies using CSII, the weighted mean difference between values obtained using SAI analogues and regular insulin was -0.19% (95% CI: -0.27 to -0.12), whereas the corresponding value for injection studies was -0.08% (95% CI: -0.15 to -0.02). For the analysis of overall hypoglycaemia, we used the results from nine studies that reported the mean frequency of hypoglycaemic episodes per patient per month. For studies using CSII, the standardised mean difference between SAI analogues and regular insulin was -0.07 (95% CI: -0.43 to 0.28), whereas for IIT studies the corresponding value was -0.04 (95% CI: -0.24 to 0.16). CONCLUSIONS/INTERPRETATION: Taking into consideration the low quality of the trials included, we can conclude that use of a short-acting insulin analogue in CSII therapy provides a small, but statistically significant improvement in glycaemic control compared with regular insulin. An even smaller effect was obtained with the use of ITT. The rate of overall hypoglycaemic episodes was not significantly reduced with short-acting insulin analogues in either injection regimen.

Adult↗

Dosimetric considerations on TEPC fluka-simulation and measurements.

The response of a tissue equivalent proportional counter (TEPC) has been simulated with the Monte Carlo transport code FLUKA. The absorbed dose distribution of lineal energy y has been determined for several monoenergetic photon and neutron sources. The agreement between the calculated results and the measurements carried out with different well-known sources is well demonstrated. Work is in progress in order to evaluate the response of the instrument in the cosmic ray environment.

Algorithms↗

Exposure of aircraft crew to cosmic radiation: on-board intercomparison of various dosemeters.

Owing to their professional activity, flight crews may receive a dose of some millisieverts within a year; airline passengers may also be concerned. The effective dose is to be estimated using various experimental and calculation tools. The European project DOSMAX (Dosimetry of Aircrew Exposure during Solar Maximum) was initiated in 2000 extending to 2004 to complete studies over the current solar cycle during the solar maximum phase. To compare various dosemeters in real conditions simultaneously in the same radiation field, an intercomparison was organised aboard a Paris-Tokyo round-trip flight. Both passive and active detectors were used. Good agreement was observed for instruments determining the different components of the radiation field; the mean ambient dose equivalent for the round trip was 129 +/- 10 microSv. The agreement of values obtained for the total dose obtained by measurements and by calculations is very satisfying.

Aircraft↗

The pharmacokinetics of s.c. Semitard MC, human NPH ge, Rapitard MC and human NPH 30:70 ge insulin in healthy, non-diabetic subjects.

BACKGROUND: Plasma glucose and insulin responses to Semitard MC versus human NPH ge and Rapitard MC versus human NPH 30:70 ge were examined in fasted healthy, non-diabetic subjects. METHODS: Twelve male subjects with a mean (+/-S.D.) age of 33.9+/-11.1 years and a BMI of 24.9+/-2.9 kg/m(2) were each involved on four separate study days 1 week apart. After fasting samples were taken, 0.2 U/kg of the allocated insulin preparation was injected subcutaneously (s.c.) as a bolus into the anterior abdominal wall. Blood samples were taken over the next 24 h. RESULTS: Subcutaneous injection of Semitard MC caused a greater fall in plasma glucose concentration and lower mean plasma glucose levels throughout the study compared to NPH, reflecting the higher insulin concentrations observed during the 24-h study period. Following s.c. Rapitard MC the plasma glucose levels were consistently higher than those achieved with human NPH 30:70 ge as a result of the lower concentrations of insulin with Rapitard MC insulin. CONCLUSIONS: To obtain the same level of glycaemic control, transferring patients from Semitard MC to human NPH may require a dose increase of 30% in the first instance to be adjusted upwards as deemed necessary. Transferring patients from Rapitard MC to human NPH 30:70 ge, a dose reduction of 25% may be required. Frequent home blood glucose monitoring should be carried out.

Journal Article↗

Comparison of the subcutaneous absorption of insulin glargine (Lantus) and NPH insulin in patients with Type 2 diabetes.

The aim of this study was to compare the subcutaneous absorption characteristics of insulin glargine with NPH insulin in patients with Type 2 diabetes. In this single-dose, double-blind, randomized, two-way crossover study, 14 patients with Type 2 diabetes (aged 40-70 years) previously untreated with insulin were randomized to receive in a fasting state either a single subcutaneous injection of 0.3 U/kg 125I-insulin glargine or 0.3 U/kg 125I-NPH insulin. The disappearance of radioactivity was monitored for forty-eight hours. The median time for 25%, 50% and 75% of the radioactivity to disappear from the injection site was significantly longer for insulin glargine compared with NPH insulin (T75% 15.0 and 6.5 h, p=0.009; T50% 26.3 and 13.4 h, p=0.009; T25% 42.4 and 26.6 h, p=0.019, respectively). The mean residual radioactivity remaining at 24, 36 and 48 h after injection remained significantly higher than NPH insulin (54.4 and 27.9%, p=0.0001; 35.0 and 17.0%, p=0.003; 19.2 and 9.2%, p=0.01, respectively). Mean plasma glucose levels reached a minimum after 14.6 and 9 h in response to insulin glargine and NPH insulin, respectively. The subcutaneous absorption of insulin glargine in fasting Type 2 diabetes patients was significantly (2-3 times) slower compared with NPH insulin in patients with Type 2 diabetes. The slower absorption of insulin glargine correlated with the fall in plasma glucose levels over a 24 h period compared with the faster insulin absorption and more rapid decrease in plasma glucose levels observed in response to NPH insulin. Both insulin glargine and NPH insulin were well tolerated.

Adult↗

Recent studies on the exposure of aircrew to cosmic and solar radiation.

Investigations of the impact of cosmic and solar radiation on aircrew involve many challenges. The great variety of primary and secondary ionising and non-ionising radiation, the wide range of energies involved and the role played by the Earth's atmosphere and magnetic field and the Sun combine to produce a very complicated scenario. These factors are reflected in conditions on aviation routes where exposure to radiation varies with altitude, latitude and stage of solar cycle. The great increase in air travel and consequent rise in numbers of aircrew whose occupation requires them to work in this environment has prompted new concern about exposure risks at aviation altitudes. The situation has also been highlighted by the tendency for aircraft to fly at higher altitudes in recent years and by the 1990 recommendations of the ICRP that exposure of civil aircrew be considered as being occupational. These have recently been translated into a legal requirement in the European Union. Several studies have been completed using a very wide range of detectors on subsonic and supersonic routes and new investigations are underway. With the completion of the DOSMAX project in another three years or so. world data for a whole solar cycle will be more complete than ever before. Results indicate that for most routes investigated during solar minimum, aircrew are unlikely to receive doses in excess of 6 mSv.y(-1).

Aerospace Medicine↗

Secondary prevention following myocardial infarction: evidence from an audit in South Wales that the National Service Framework for coronary heart disease does not address all the issues.

OBJECTIVES: To assess local uptake of treatments for secondary prevention of myocardial infarction and compare with targets in the National Service Framework (NSF) for coronary heart disease. DESIGN: Retrospective audit of case notes with follow up questionnaire at 1 year. SETTING: Teaching hospital and community. PARTICIPANTS: 100 patients alive in December 1998 who had been admitted with an acute myocardial infarction between October 1997 and October 1998. MAIN OUTCOME MEASURES: Local use of aspirin, beta blockers, ACE inhibitors, and statins. RESULTS: Unless contraindicated, discharge aspirin use was 100%, beta blocker use 84%, statin prescription and/or provision of dietetic advice 66% and ACE inhibitors where any heart failure was found was 97%. 1-2 years later total cholesterol remained greater than 5.0 mmol/l in 25% of patients, 24% had stopped beta blockers, and ACE inhibitors remained at a low dose in half of those surveyed. CONCLUSIONS: The NSF for coronary heart disease states that by April 2002 80-90% of patients should be prescribed appropriate secondary prevention. This had nearly been achieved at hospital discharge in 1999. However, follow up indicated problems in ongoing care with cholesterol targets not always being achieved, beta blockers often being stopped, and ACE inhibitors frequently remaining at low doses. Gaining maximum benefit from treatment depends on these secondary targets also being achieved. In these aspects of secondary prevention the NSF represents only an initial step towards effective prevention of coronary heart disease; perhaps the most difficult and expensive steps are yet to be fully realised.

Adrenergic beta-Antagonists↗

Gene function analysis by amber stop codon suppression: CMBF is a nuclear protein that supports growth and development of Dictyostelium amoebae.

The C-module-binding factor, CMBF, is a nuclear DNA-binding protein which was originally identified through its specific binding to a promoter element within the retrotransposable element TRE5-A of Dictyostelium discoideum AX2 cells. In order to analyse putative physiological functions of CMBF for the TRE5-A-hosting D. discoideum cells, we used a novel strategy to create mutant cell lines which stably underexpressed functional CMBF. An amber (UAG) translation stop codon was introduced into the chromosomal copy of the CMBF-encoding gene (cbfA), and an amber suppressor tRNA gene was expressed in the same mutant cells. Due to the low efficiency of translation stop codon suppression in this system all recovered cell lines expressed <20 % of wild-type CMBF levels. The mutant cell lines displayed strong growth phenotypes when plated on their natural food source, bacteria. We show evidence that growth reduction was due to impaired phagocytosis of bacteria in the mutants. All obtained mutants showed a strong developmental defect which was defined by the formation of very small fruiting bodies. The strength of the developmental phenotype appeared to depend upon the residual CMBF levels maintained in the mutants. We propose that CMBF is a general transcription regulator which supports the normal expression of several genes required for the maintenance of high proliferation rates of D. discoideum amoebae as well as proper aggregation and development. Our results demonstrate that amber stop codon suppression may be a useful strategy to stably underexpress proteins whose coding genes cannot be successfully disrupted by homologous recombination.

Active Transport, Cell Nucleus↗

[Economic impact of rationalized antibiotic therapy in a general hospital].

PURPOSE: To evaluate the economic impact and the bacterial resistance rates after 2 years of a rationalized antibiotic prescription program in a 502-bed hospital. CURRENT KNOWLEDGE AND KEY POINTS: Prescribing protocols were established by consensus in 1998 and were reinforced a year later by nominative dispensing of the most costly antibiotics. The impact of the program was assessed in terms of changes in the overall cost of antibiotics and in the pattern of bacterial resistance among pathogens isolated in the institution, during the period prior to the onset of the program (1997) and its realization (1998 and 1999). FUTURE AND PROJECTS: The expenses for antibiotic drugs decreased by 46% in 2 years. Resistance rates among the different pathogens studied have remained stable. No increase of mortality was observed. Our rational policy in antibiotic therapy had a positive economic impact. However, new additional measures should be encouraged to prevent antimicrobial resistance.

Anti-Bacterial Agents↗

Oral 5-aminosalicylic acid for inducing remission in ulcerative colitis.

OBJECTIVES: To assess the efficacy, dose-responsiveness and safety of the newer release formulations of 5-aminosalicylic acid (5-ASA) compared to placebo or sulfasalazine (SASP) for the induction of remission in active ulcerative colitis. SEARCH STRATEGY: A computer-assisted literature search for relevant studies (1981-1998) was performed using MEDLINE, BIOS, the Cochrane Controlled Trials Register and the Science Citation Index, followed by a manual search of reference lists from previously retrieved articles, review articles, symposia proceedings, and abstracts from major gastrointestinal conferences. SELECTION CRITERIA: Studies were accepted for analysis if they were randomized, double-blinded, and controlled clinical trials of parallel design, with treatment durations of a minimum of four weeks. DATA COLLECTION AND ANALYSIS: Based on an intention to treat principle, the outcomes of interest in the treatment of active disease were the failure to induce global/clinical remission, global/clinical improvement, endoscopic remission, or endoscopic improvement. MAIN RESULTS: 5-ASA was superior to placebo with regard to all measured outcome variables. For the failure to induce global/clinical improvement or remission, the pooled Peto odds ratio was 0.51 (95% CI, 0.35 to 0.76). A dose-response trend for 5-ASA was also observed. When 5-ASA was compared to SASP, the pooled Peto odds ratio was 0.87 (CI, 0.63 to 1.21) for the failure to induce global/clinical improvement or remission, and 0.66 (CI, 0.42 to 1.04) for the failure to induce endoscopic improvement. SASP was not as well tolerated as 5-ASA. REVIEWER'S CONCLUSIONS: The newer 5-ASA preparations were superior to placebo and tended towards therapeutic benefit over SASP. However, considering their relative costs, a clinical advantage to using the newer 5-ASA preparations in place of SASP appears unlikely.

Aminosalicylic Acids↗

Oral 5-aminosalicylic acid for maintaining remission in ulcerative colitis.

OBJECTIVES: To assess the efficacy, dose-responsiveness and safety of the newer release formulations of 5-aminosalicylic acid (5-ASA) compared to placebo or sulfasalazine (SASP) in the maintenance of remission in ulcerative colitis. SEARCH STRATEGY: A computer-assisted literature search for relevant studies (1981-1998) was performed using MEDLINE, BIOS, the Cochrane Controlled Trials Register, the Inflammatory Bowel Disease Trials Register, and Science Citation Index, followed by a manual search of reference lists from previously retrieved articles, review articles, symposia proceedings, and abstracts from major gastrointestinal conferences. SELECTION CRITERIA: Studies were accepted for analysis if they were prospective, randomized, double-blinded, and placebo- or SASP-controlled clinical trials of parallel design with treatment duration of at least six months. DATA COLLECTION AND ANALYSIS: Based on an intention to treat principle, the primary outcome was the failure to maintain clinical or endoscopic remission. Secondary outcomes were the number of patients experiencing adverse events, the number of patients withdrawn due to adverse events, and exclusions or withdrawals after entry into the study (not due to relapse). All data were analyzed using the Peto odds ratio and corresponding 95% confidence intervals (CI). MAIN RESULTS: The Peto odds ratio for the failure to maintain clinical or endoscopic remission (withdrawals and relapses) for 5-ASA versus placebo was 0. 47 (95% CI, 0.36 to 0.62) with an NNT of 6. These values were also calculated for the trials in which SASP and 5-ASA were compared, revealing an odds ratio of 1.29 (95% CI, 1.05 to 1.57), with a negative NNT value (-19), suggesting a higher degree of therapeutic effectiveness for SASP. SASP and 5-ASA had similar adverse event profiles, with odds ratios of 1.16(0.62 to 2.16), and 1.31(0.86 to 1.99), respectively. The NNH values were determined to be 171 and 78 respectively. REVIEWER'S CONCLUSIONS: The newer 5-ASA preparations were superior to placebo in maintenance therapy. However, the newer preparations had a statistically significant therapeutic inferiority relative to SASP.

Administration, Oral↗